A review on triple-negative breast cancer and its potential treatment

A review on triple-negative breast cancer and its potential treatment

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.

Бібліографічні деталі
Автор:	Niasa, Jannatul Ferdous
Інші автори:	Chowdhury, Namara Mariam
Формат:	Дисертація
Мова:	English
Опубліковано:	Brac University 2023
Предмети:	TNBC HER-2 receptors Anti-cancer therapeutics Signaling pathways Breast > Cancer > Patients Breast > Cancer > Treatment
Онлайн доступ:	http://hdl.handle.net/10361/17766

Схожі ресурси

Targeted therapeutic options in the treatment of Breast Cancer
за авторством: Alam, Kazi Tasnuva
Опубліковано: (2022)

Recent advancement on breast cancer detection and treatment
за авторством: Rahman, Sanjida
Опубліковано: (2023)

Natural products and their combinatory effects in breast cancer treatment
за авторством: Siddique, Md. Ayman
Опубліковано: (2021)

Drug repurposing: potential of Antimicrobial Drugs in Breast Cancer Treatment
за авторством: Chakraborty, Anuradha
Опубліковано: (2024)

Breast cancer awareness seminars
за авторством: Anwer Khan Modern Medical College
Опубліковано: (2016)

The impact of breast cancer on women’s lives in Bangladesh
за авторством: Mobashera, Tayeeba Tum
Опубліковано: (2024)

Comparison of conventional doxorubicin with liposome encapsulated doxorubicin as a treatment of breast cancer-a review
за авторством: Akter, Honufa
Опубліковано: (2024)

A review of Breast Cancer risk factor assessment on women in developing countries, cancer drug resistance, and Breast Cancer treatment in Bangladesh
за авторством: Raihan, Dilraj
Опубліковано: (2024)

RIPK pathway, as a potential target, for cancer treatment - a review
за авторством: Jahan, Nusrat
Опубліковано: (2024)

Pooled analysis of progression-free survival and overall survival in phase II clinical trials of breast cancer
за авторством: Shobnam, Sohana
Опубліковано: (2024)

Association of BRCA1, BRCA2, RAD51, and HER2 gene polymorphisms with the breast cancer risk in the Bangladeshi population
за авторством: Parvin, Salma, та інші
Опубліковано: (2016)

Breast cancer therapy through Liposomal drug delivery system
за авторством: Ome, Nusrat Jahan
Опубліковано: (2024)

Machine learning as an indicator for breast cancer prediction
за авторством: Shadman, Tahsin Mohammed, та інші
Опубліковано: (2019)

Targeting DHFR in breast cancer: exploring expression patterns and identifying potential inhibitors through docking studies
за авторством: Araf, Faiaz Fahim
Опубліковано: (2024)

Breast cancer in low-resource settings: Prioritizing the awareness and access programmes to overcome sociocultural and economic barriers for early detection and improved outcomes
за авторством: Iqbal, Mohammad Shamim, та інші
Опубліковано: (2017)

A review on the potential of repurposing of metformin for colon cancer and breast cancer
за авторством: Oishy, Jannatun Noor
Опубліковано: (2024)

Tamoxifen: The ideal post operative hormonal therapy to demote Ductal Carcinoma in Situ
за авторством: Mirza, Maisa Tasnim
Опубліковано: (2023)

Role of toll-like receptors in cancer immunotherapy– a review
за авторством: Khan, Rezia Nowrin
Опубліковано: (2021)

Pathway analysis of Disease-Gene associated network in the human breast cancer
за авторством: Lamia
Опубліковано: (2020)

In silico analysis revealed hsa-miR-19a-3p and hsa-miR-19b-3p as two potential inhibitors of EGF mRNA in Breast Cancer
за авторством: Nuha, Nabiha Tahsin
Опубліковано: (2024)

Early detection of breast cancer using machine learning
за авторством: Fuad, Wasi Mohammad
Опубліковано: (2019)

Breast cancer in South Asia: a Bangladeshi perspective
за авторством: Hossain, Mohammad Sorowar, та інші
Опубліковано: (2017)

A review on potential of PARP inhibitors in the treatment of prostate cancer
за авторством: Islam, Saidul
Опубліковано: (2022)

Palliative care services in cancer treatment: a study of the current scenario in Dhaka
за авторством: Rahman, Qazi Ashrafur
Опубліковано: (2018)

Breast cancer prediction using different machine learning models
за авторством: Khandker Al- Muhaimin, та інші
Опубліковано: (2020)

Current practice and approaches of immunotherapy in Cancer treatment
за авторством: Khondokar, Faiza
Опубліковано: (2022)

Genetic innovations for breast cancer treatment : a review of gene therapy strategies and future implications
за авторством: Hasan, Sakib
Опубліковано: (2024)

Potential phytochemicals and dietary components for the prevention and treatment of skin cancer: A review
за авторством: Muntaha, Habibatul
Опубліковано: (2023)

Potential of liposomes for the treatment of lung cancer- a review
за авторством: Mim, Shanzida
Опубліковано: (2023)

Role of statins as antagonists of SPARC in gastric cancer
за авторством: Shahmat, Rad
Опубліковано: (2019)

A review on newly approved PARP inhibitors: Talazoparib and Olaparib
за авторством: Karim, Azrin
Опубліковано: (2024)

Stem cells as therapeutic carrier in cancer treatment
за авторством: Anika, Mysha Yeasmin
Опубліковано: (2022)

Microneedles in pain management of Cancer
за авторством: Islam, Shafiqul
Опубліковано: (2022)

Biosimilar in lymphoma treatment
за авторством: Tanisha, Mehrin Haque
Опубліковано: (2021)

A systematic review on the comparison of FOLFIRI and FOLFOX based chemotherapies in the treatment of metastatic colorectal Cancer
за авторством: Islam, Nurjahan
Опубліковано: (2022)

An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer
за авторством: Hasan, Amit
Опубліковано: (2024)

A comprehensive review on drug repurposing in cancer treatment
за авторством: Sarkar, Onusree
Опубліковано: (2024)

Targeting BRAFV600E in the treatment of CRC
за авторством: Roja, Mashwiyat Samrin
Опубліковано: (2024)

Machine learning In breast cancer prognosis and prediction
за авторством: Chowdhury, Shah Abul Hasnat, та інші
Опубліковано: (2023)

Statistics and informatics in molecular cancer research